Found: 4
Select item for more details and to access through your institution.
Hyper-N-glycosylated SEL1L3 as auto-antigenic B-cell receptor target of primary vitreoretinal lymphomas.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-60169-5
- By:
- Publication type:
- Article
Ars2‐containing bispecific, Fab‐ and IgG1‐format BAR‐bodies to target DLBCL cells.
- Published in:
- EJHaem, 2023, v. 4, n. 1, p. 125, doi. 10.1002/jha2.635
- By:
- Publication type:
- Article
Integration of the B-Cell Receptor Antigen Neurabin-I/SAMD14 Into an Antibody Format as New Therapeutic Approach for the Treatment of Primary CNS Lymphoma.
- Published in:
- Frontiers in Oncology, 2020, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.580364
- By:
- Publication type:
- Article
Sammelrezension: Defizite in der UN-Friedenspraxis.
- Published in:
- Femina Politica, 2020, v. 29, n. 2, p. 167, doi. 10.3224/feminapolitica.v29i2.36
- By:
- Publication type:
- Article